[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642212":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":10,"responsibleParty":24,"collaborators":10,"id":26,"slug":27,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":30,"acronym":10,"eligibilityCriteria":31,"healthyVolunteers":28,"sex":32,"minAge":33,"maxAge":10,"enrollmentInfo":34,"targetDuration":37,"studyType":38,"phases":10,"briefSummary":39,"conditions":40,"keywords":10,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":10},{"fullName":5,"class":6},"Kardium Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Globe Pulsed Field System",null,[12],"Device: Globe Pulsed Field System",[14],{"type":15,"name":9,"description":16,"armGroupLabels":17,"otherNames":10},"DEVICE","Ablation and atrial mapping with the Globe Pulsed Field System",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Clinical Affairs","CONTACT","+1 (604) 248 8891","Clinical.Affairs@kardium.com",{"type":25,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100642212","globe-registry-globe-pulsed-field-system-registry-study-for-treating-patients-with-symptomatic-atrial-fibrillation-100642212",false,"NCT07651852","Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation","Key Inclusion Criteria:\n\n* Patients with a planned ablation procedure using the commercially available Globe PF System\n\nKey Exclusion Criteria:\n\n* Patients whose life expectancy is 1 year or less\n* Contraindication to left atrial catheter ablation or PF ablation\n* Current enrollment in any investigational study of a medical device, biologic, or drug not pre-approved by Kardium","ALL","18 Years",{"count":35,"type":36},500,"ESTIMATED","12 Months","OBSERVATIONAL","This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).",[41],"Atrial Fibrillation","NOT_YET_RECRUITING","2026-06-11",{"date":45,"type":46},"2026-06-16","ACTUAL",{"date":48,"type":36},"2026-07",{"date":50,"type":36},"2029-10",{"name":5,"class":6}]